Divis Laboratories Ltd | DIVI - EPS Earnings Per Share



Divis Laboratories Ltd reported 20.49 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Sep/2025 24.74 19.20 Nov/10 2025
FY2026Q1 Jun/2025 20.49 22.07 16.20 Aug/06 2025
FY2025Q4 Mar/2025 24.90 20.67 20.30 May/17 2025
FY2025Q3 Dec/2024 22.20 19.03 13.49 Feb/03 2025
FY2025Q2 Sep/2024 19.20 18.32 Nov/08 2024
FY2025Q1 Jun/2024 16.20 16.19 Aug/02 2024
FY2024Q4 Mar/2024 20.30 20.25 12.1 May/25 2024
FY2024Q3 Dec/2023 13.50 13.38 11.15 Feb/10 2024
FY2024Q2 Sep/2023 13.10 18.6 Nov/06 2023
FY2024Q1 Jun/2023 13.40 26.4 Aug/14 2023
FY2023Q4 Mar/2023 12.10 33.7 May/20 2023
FY2023Q3 Dec/2022 11.60 34 Feb/03 2023


Eps Change Date
Alaunos Therapeutics USD -0.46 0.24 Dec/2024
Aurobindo Pharma INR 14.2 1.36 Jun/2025
Avita Medical USD -0.21 0.05 Dec/2024
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Divis Laboratories Ltd 20.49 4.26 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
IQVIA Holdings USD 2.81 0.11 Jun/2025
Lupin INR 23.6 6.68 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Organon & Co USD 1 0.02 Jun/2025
Revvity USD 1.18 0.17 Jun/2025
Tectonic Therapeutic USD -1.07 0.23 Jun/2025
Tilray USD -1.78 0.54 Jun/2025
Viatris USD 0.62 0.12 Jun/2025
Xeris Pharmaceuticals USD -0.01 0.02 Jun/2025